Abstract
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have